Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis.

Wang, Qingyi; Feng, Xiaoling; Liu, Xiaofang; Zhu, Siyu

Wang, Qingyi; Feng, Xiaoling; Liu, Xiaofang; Zhu, Siyu.

Afiliação

Wang Q; Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Feng X; Department of Gynecology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Liu X; Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Zhu S; Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.

Front Oncol ; 12: 868061, 2022.

Article em En | MEDLINE | ID: mdl-35463345

Palavras-chave

CA-125; meta-analysis; neoadjuvant chemotherapy; ovarian cancer; overall survival; prognosis; progress-free survival; systematic review

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google